Ben Tre Pharmaceutical JSC

44
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DBT6
VND
12,600.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Ben Tre Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
24,008.00
20,379.00
23,095.00
50,861.00
17,699.00
17,152.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-27,224.00
-48,161.00
-29,179.00
-42,574.00
-38,096.00
-120,040.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-5,581.00
-23,760.00
3,173.00
-32,682.00
-35,191.00
-89,626.00
Cash Flow from Investing Activities
14,975.00
-35,576.00
-65,377.00
-359.00
74,803.00
-8,588.00
Cash Flow from Financing Activities
3,589.00
46,546.00
69,935.00
27,216.00
-52,343.00
98,100.00
Net Cash Inflow / Outflow
12,988.00
-12,784.00
7,754.00
-6,069.00
-12,679.00
-141.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
6.00
23.00
-243.00
51.00
-26.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ben Tre Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
24008.057991
53134.785677
-29,126.00
-54.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-27224.021463
-45203.133376
17,979.00
39.77%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-5581.489497
62837.048196
-68,418.00
-108.88%
Cash Flow from Investing Activities
14975.240312
-6772.677171
21,747.00
321.11%
Cash Flow from Financing Activities
3589.866003
-12634.1105
16,223.00
128.41%
Net Cash Inflow / Outflow
12988.007954
43663.112395
-30,675.00
-70.25%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.391136
232.85187
-228.00
-98.11%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 76.51% vs -848.72% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-5,581.49
-23,760.64
76.51%